These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8641043)

  • 21. Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
    Kragten JA; Dunselman PH
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):643-53. PubMed ID: 17605643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

  • 24. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcium channel antagonists: morbidity and mortality--what's the evidence?
    Straka RJ; Swanson AL; Parra D
    Am Fam Physician; 1998 Apr; 57(7):1551-60. PubMed ID: 9556644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Korinfar in the treatment of patients with arterial hypertension].
    Lautsevichus LZ; Kibarskis KhKh; Razukas VA; Nauiokaĭtene RS
    Vrach Delo; 1986 Sep; (9):26-8. PubMed ID: 3788106
    [No Abstract]   [Full Text] [Related]  

  • 29. [New nifedipine preparation makes single daily dose possible].
    Fortschr Med; 1997 Nov; 115(33):following 54. PubMed ID: 9480274
    [No Abstract]   [Full Text] [Related]  

  • 30. [Efficacy of antihypertensive drugs in pregnancy].
    Tsaava F; Shonia R
    Georgian Med News; 2005 Sep; (126):23-6. PubMed ID: 16234587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Calcium antagonists in treatment of hypertension. Proper selection and drug combinations if needed].
    Trenkwalder P
    MMW Fortschr Med; 2001 May; 143(22):27-8. PubMed ID: 11460394
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features and up-to-date therapy of hypertensive emergencies].
    Meyer FP
    Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug-induced gingival hyperplasia].
    Nohl F; Ferrari P
    Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nifedipine scare in hypertension: fact or fiction.
    Gambhir DS
    Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005
    [No Abstract]   [Full Text] [Related]  

  • 36. The FDA's decisions regarding new indications for approved drugs. Where's the evidence?
    Winker MA
    JAMA; 1996 Oct 23-30; 276(16):1342-3. PubMed ID: 8861995
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lowering blood pressure with new calcium antagonists. High benefit by innovative mechanism of action].
    MMW Fortschr Med; 2005 Feb; 147(5):46-7. PubMed ID: 15766029
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
    Nakayama J; Koga T; Furue M
    Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive role of glossopharyngeal nerve stimulation by nifedipine using as calcium channel blocking agent in hypertension: an experimental study.
    Aydin MD; Bayram E; Halici Z; Aydin N; Atalay C; Ulvi H; Kotan D; Gundogdu C
    Arch Pharm Res; 2009 Nov; 32(11):1607-11. PubMed ID: 20091275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The calcium channel antagonist controversy.
    Gavras I; Gavras H
    Am Fam Physician; 1998 Apr; 57(7):1484, 1492. PubMed ID: 9556636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.